Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 104652
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104652
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104652
Table 1 The preoperative characteristics of patients in the three groups who underwent pancreaticoduodenectomy, n (%)
Characteristics | EDS group (n = 129) | IDS group (n = 71) | NDS group (n = 44) | P value |
Age, years | 68 (45-86) | 64 (17-85) | 66 (16-89) | 0.091 |
Sex, male/female | 65/64 (50.4/ 49.6) | 43/28 (60.6/39.4) | 24/20 (54.5/45.5) | 0.384 |
ASA score | 0.652 | |||
I-II | 62 (48.1) | 38 (53.6) | 22 (50) | |
III-IV | 67 (51.9) | 33 (46.4) | 22 (50) | |
Body mass index, kg/m2 | 24.6 (16-41) | 25.2 (14-43.3) | 24.5 (18-36.3) | 0.760 |
Comorbidities | ||||
Cardiovascular | 68 (52.7) | 32 (45.1) | 22 (50) | 0.124 |
Hypertension | 59 (45.7) | 31 (43.7) | 16 (36.4) | 0.556 |
Smoker | 28 (21.7) | 17 (23.9) | 8 (18.2) | 0.887 |
Diabetes | 27 (20.9) | 23 (32.4) | 14 (31.8) | 0.109 |
Pulmonary | 24 (18.6) | 18 (25.3) | 8 (18.2) | 0.096 |
Tumor | 19 (14.7) | 9 (12.7) | 8 (18.2) | 0.549 |
Alcohol use | 18 (14) | 10 (14.1) | 4 (9.1) | 0.886 |
Neoadjuvant chemotherapy | 19 (14.7) | 7 (9.9) | 2 (4.5) | 0.165 |
Clinical | ||||
Jaundice | 84 (65.1) | 42 (59.2) | 24 (54.5) | 0.412 |
Weight loss | 72 (55.8) | |||
Abdominal pain | 62 (48.1) | 25 (35.2) | 18 (40.9) | 0.204 |
Cholangitis | 24 (18.6) | 13 (18.3) | 8 (18.2) | 0.997 |
Preoperative pancreatitis | 10 (7.8) | 6 (8.5) | 12 (27.3) | 0.001 |
Duodenal obstruction | 9 (7) | 4 (5.6) | 0 (0) | 0.203 |
Upper gastrointestinal bleeding | 8 (6.2) | 3 (4.2) | 2 (4.5) | 0.811 |
Diagnostic examinations/findings | ||||
CT scan | 126 (97.7) | 69 (97.2) | 43 (97.7) | 0.973 |
MRI | 91 (70.5) | 53 (74.6) | 30 (68.2) | 0.728 |
Endoscopic ultrasound | 73 (56.6) | 49 (69) | 27 (61.4) | 0.226 |
ERCP | 64 (49.6) | 38 (53.5) | 23 (52.3) | 0.886 |
PTHC | 19 (14.7) | 8 (11.3) | 3 (6.8) | 0.368 |
Tumor size, cm | 2.2 (0.1-6) | 2.1 (0.2-7.1) | 2 (0.2-5.5) | 0.653 |
Bile duct size, cm | 1.2 (0.3-2.5) | 1.2 (0.2-2.4) | 1 (0.2-3.1) | 0.303 |
Preoperative biliary stent | 0.127 | |||
No stent | 78 (60.5) | 37 (52.1) | 23 (52.3) | |
Stent | 51 (39.5) | 34 (47.9) | 21 (47.7) | |
Laboratory findings | ||||
Hemoglobin, g/dL | 13.1 (9.1-17.2) | 12.6 (10-16) | 13 (11.2-16) | 0.401 |
Platelet count, × 103 | 238 (59-431) | 236 (130-487) | 227 (80-390) | 0.103 |
INR | 1 (0.7-1.34) | 1.02 (0.89-1.26) | 1 (0.87-1.47) | 0.664 |
Creatinine, mg/dL | 0.78 (0.38-1.62) | 0.76 (0.52-2.48) | 0.77 (0.53-2.15) | 0.379 |
Glycemia, mg/dL | 105 (56-304) | 92 (77-107) | 120 (76-267) | 0.401 |
Bilirubin, mg/dL | 2.7 (0.2-26) | 1.2 (0.2-2.4) | 4.2 (0.2-28.9) | 0.475 |
GOT, IU/L | 60 (14-571) | 63 (17-372) | 79 (12-1140) | 0.658 |
GPT, IU/L | 226 (10-2246) | 281 (9-1877) | 228 (8-1407) | 0.877 |
GGT, IU/L | 76 (13-584) | 117 (13-933) | 89 (9-1682) | 0.554 |
Alkaline phosphatase, U/L | 274 (39-2262) | 191 (42-1378) | 359 (31-1441) | 0.799 |
CA19-9, U/mL | 75.4 (3-13950) | 28.1 (21-950) | 16.5 (10-1052) | 0.004 |
CEA, ng/mL | 2.7 (0.1-831) | 0.53 (0-33.7) | 2.8 (0.7-48) | 0.313 |
Cytology | 23 (17.8) | 10 (14.1) | 5 (11.4) | 0.545 |
- Citation: Jiménez-Romero C, Marcacuzco-Quinto A, Caso-Maestro O, Alonso L, Fernández-Fernández C, Justo I. Comparison of three reconstruction techniques performed after pancreaticoduodenectomy: Using external, internal, or no stent. World J Gastrointest Surg 2025; 17(6): 104652
- URL: https://www.wjgnet.com/1948-9366/full/v17/i6/104652.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i6.104652